VIKING THERAPEUTICS INC's ticker is VKTX and the CUSIP is 92686J106. A total of 147 filers reported holding VIKING THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 0.76 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $760,079 | -31.6% | 68,662 | +0.2% | 0.00% | 0.0% |
Q2 2023 | $1,110,572 | +45.1% | 68,512 | +49.0% | 0.00% | 0.0% |
Q1 2023 | $765,417 | -13.3% | 45,971 | -51.0% | 0.00% | 0.0% |
Q4 2022 | $882,350 | +209.6% | 93,867 | -10.4% | 0.00% | – |
Q3 2022 | $285,000 | -12.8% | 104,728 | -7.3% | 0.00% | – |
Q2 2022 | $327,000 | -11.9% | 113,009 | -8.7% | 0.00% | – |
Q1 2022 | $371,000 | -41.2% | 123,751 | -9.8% | 0.00% | -100.0% |
Q4 2021 | $631,000 | -60.0% | 137,215 | -45.4% | 0.00% | 0.0% |
Q3 2021 | $1,578,000 | +1.5% | 251,336 | -3.1% | 0.00% | 0.0% |
Q2 2021 | $1,554,000 | -38.8% | 259,421 | -35.4% | 0.00% | -66.7% |
Q1 2021 | $2,541,000 | +53.8% | 401,730 | +36.9% | 0.00% | +50.0% |
Q4 2020 | $1,652,000 | -25.4% | 293,381 | -22.9% | 0.00% | -33.3% |
Q3 2020 | $2,213,000 | -19.2% | 380,316 | +0.1% | 0.00% | -25.0% |
Q2 2020 | $2,740,000 | +126.1% | 380,044 | +46.7% | 0.00% | +100.0% |
Q1 2020 | $1,212,000 | -42.3% | 259,058 | -1.0% | 0.00% | -33.3% |
Q4 2019 | $2,099,000 | -8.7% | 261,772 | -24.1% | 0.00% | 0.0% |
Q3 2019 | $2,300,000 | -17.0% | 344,992 | -0.0% | 0.00% | -25.0% |
Q2 2019 | $2,771,000 | -15.4% | 345,073 | +4.7% | 0.00% | -20.0% |
Q1 2019 | $3,277,000 | +159.3% | 329,726 | +99.5% | 0.01% | +150.0% |
Q4 2018 | $1,264,000 | -49.3% | 165,269 | +15.5% | 0.00% | -50.0% |
Q3 2018 | $2,494,000 | – | 143,147 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
APIS CAPITAL ADVISORS, LLC | 148,000 | $1,638,360 | 2.12% |
Sio Capital Management, LLC | 595,002 | $6,586,672 | 2.04% |
5AM Venture Management, LLC | 585,000 | $6,475,950 | 1.86% |
Artia Global Partners LP | 383,580 | $4,246,231 | 1.76% |
Integral Health Asset Management, LLC | 800,000 | $8,856,000 | 1.23% |
Boxer Capital, LLC | 2,000,000 | $22,140,000 | 1.18% |
DAFNA Capital Management LLC | 319,655 | $3,538,581 | 1.10% |
Affinity Asset Advisors, LLC | 332,600 | $3,681,882 | 1.04% |
MPM BioImpact LLC | 325,000 | $3,597,750 | 0.96% |
Affinity Asset Advisors, LLC | 300,000 | $3,321,000 | 0.93% |